At present, the Group has applied for a total of 68 patents (including 26 Chinese invention patents, 35 Chinese utility model patents, 2 Chinese design patents; 2 Hong Kong patents; 3 PCT patents); 36 authorized patents; 53 trademark applications , 36 registered trademarks.

A New Process for the Preparation of Recombinant Exendin-4 Polypeptides - Invention Patent Certificate

Inverted microscope for detection of recombinant human epidermal growth factor-utility model patent certificate

A Vacuum Emulsifier for Recombinant Human Epidermal Growth Factor Processing - Utility Model Patent Certificate

Abbe refractometer for rhEGF detection - utility model patent certificate

Bioreactor for rhEGF production - utility model patent certificate

Portable gas detector for rhEGF processing environment measurement - utility model patent certificate

Ultrasonic Cell Disruptor for Recombinant Human Epidermal Growth Factor Production - Utility Model Patent Certificate

A new mutant of human epidermal growth factor EN-46 - invention patent certificate